Oncology One is focused on building a diversified small molecule oncology pipeline and aims to help translate more of Australia’s world-class cancer research into treatments. Oncology One has a purpose-built business model to deliver targeted investment to research teams and works with them to progress important research towards the clinic. We are working to curate and develop high quality programs that aim to meet yet unmet clinical needs in oncology, inclusive of underserved areas such as paediatric and rare cancers. To learn more about investment or partnership opportunities with Oncology One, visit oncologyone.com.au